Harrow HROW
NASDAQ HROW
$30.61 -0.19 (-0.62%)
At close: Oct 1, 2026 · 4:00 PM EDT

Harrow (HROW) Non Operating Interest Expenses (2010 - 2026)

Updated

Harrow (HROW) posted Non Operating Interest Expenses of $6.26 million for Q2 2026, down 2.3% from $6.41 million a year earlier but up 13.9% from the prior quarter.

Analysis

Harrow (HROW) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Harrow was $22.98 million, down 7.5% year-over-year; for FY2025, it came in at $24.18 million, up 6.1% from FY2024.

  • Annual Non Operating Interest Expenses has increased for four consecutive years, with a four-year compound annual growth rate of 45.2% (FY2021 to FY2025).
  • In prior years, Harrow's Non Operating Interest Expenses was $22.79 million in FY2024 (+6.9%), $21.32 million in FY2023 (+194.4%), $7.24 million in FY2022 (+33.3%) and $5.44 million in FY2021.
  • Quarterly Non Operating Interest Expenses has run from a low of $1.69 million in Q3 2021 to a high of $6.55 million in Q1 2025 over five years.
  • On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last three quarters, with growth averaging 3.9% over the last eight quarters.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2022, with growth of 249.3%; the weakest was Q4 2025, with a decline of 18.7%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $5.5 million (Q1 2026), $5.19 million (Q4 2025) and $6.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Harrow 1.15 Bn 828.41 Mn 50.36 Mn 6.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.26 Mn
Mar 31, 2026 5.50 Mn
Dec 31, 2025 5.19 Mn
Sep 30, 2025 6.04 Mn
Jun 30, 2025 6.41 Mn
Mar 31, 2025 6.55 Mn
Dec 31, 2024 6.38 Mn
Sep 30, 2024 5.53 Mn
Jun 30, 2024 5.47 Mn
Mar 31, 2024 5.42 Mn
Dec 31, 2023 5.12 Mn
Sep 30, 2023 5.75 Mn
Jun 30, 2023 5.70 Mn
Mar 31, 2023 4.75 Mn
Dec 31, 2022 1.86 Mn
Sep 30, 2022 1.80 Mn
Jun 30, 2022 1.79 Mn
Mar 31, 2022 1.79 Mn
Dec 31, 2021 1.92 Mn
Sep 30, 2021 1.69 Mn
API Access

Harrow Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=HROW&period=max&api_key=YOUR_API_KEY